| PERIOD ENDING | 30-Sep-09 | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 | | Total Revenue | 180,826 | 167,333 | 154,487 | 159,840 | | Cost of Revenue | 68,488 | 68,549 | 66,989 | 65,929 | | | Gross Profit | 112,338 | 98,784 | 87,498 | 93,911 | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | 12,418 | 11,884 | 11,590 | 10,638 | | Non Recurring |
-
|
-
|
-
|
-
| | Others | 28,465 | 28,036 | 29,142 | 25,391 | | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | 71,455 | 58,864 | 46,766 | 57,882 | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 909 | 1,273 | 133 | 1,156 | | Earnings Before Interest And Taxes | 72,364 | 70,137 | 36,899 | 59,038 | | Interest Expense | 17,256 | 17,434 | 16,003 | 17,365 | | Income Before Tax | 55,108 | 52,703 | 20,896 | 41,673 | | Income Tax Expense | 21,638 | 16,850 | 12,525 | 16,008 | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | 33,470 | 25,853 | 18,371 | 25,665 | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 33,470 | 25,853 | 18,371 | 25,665 | | Preferred Stock And Other Adjustments |
-
| (37) | 37 |
-
| | | Net Income Applicable To Common Shares | $33,470 | $25,816 | $18,408 | $25,665 |
|
0.01% Nasdaq 
0.22%
Income Statement
